These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29656250)

  • 1. Exposure to environmental level phenanthrene induces a NASH-like phenotype in new born rat.
    Guo J; Wang C; Guo Z; Zuo Z
    Environ Pollut; 2018 Aug; 239():261-271. PubMed ID: 29656250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent exposure to environmental level of PCBs (Aroclor 1254) induces non-alcoholic fatty liver disease in male mice.
    Ruan J; Guo J; Huang Y; Mao Y; Yang Z; Zuo Z
    Environ Res; 2020 Feb; 181():108909. PubMed ID: 31776016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
    Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
    BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
    Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
    Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
    Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero exposure to phenanthrene induces hepatic steatosis in F1 adult female mice.
    Guo J; Zhang S; Fang L; Huang J; Wang Q; Wang C; Chen M
    Chemosphere; 2020 Nov; 258():127360. PubMed ID: 32554016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
    Zhong X; Liu H
    J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study.
    Rantakokko P; Männistö V; Airaksinen R; Koponen J; Viluksela M; Kiviranta H; Pihlajamäki J
    Environ Health; 2015 Sep; 14():79. PubMed ID: 26420011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
    Chtourou Y; Fetoui H; Jemai R; Ben Slima A; Makni M; Gdoura R
    Eur J Pharmacol; 2015 Jan; 746():96-105. PubMed ID: 25446569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term exposure to phenanthrene at environmental-level induces intestinal dysbiosis and disrupted hepatic lipid metabolism in mice.
    Yu X; Lv K; Guan S; Zhang X; Sun L
    Environ Pollut; 2021 Jan; 268(Pt B):115738. PubMed ID: 33022571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
    Ratziu V; Harrison SA; Francque S; Bedossa P; Lehert P; Serfaty L; Romero-Gomez M; Boursier J; Abdelmalek M; Caldwell S; Drenth J; Anstee QM; Hum D; Hanf R; Roudot A; Megnien S; Staels B; Sanyal A;
    Gastroenterology; 2016 May; 150(5):1147-1159.e5. PubMed ID: 26874076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
    Christensen CU; Glavind E; Thomsen KL; Kim YO; Heebøll S; Schuppan D; Hamilton-Dutoit S; Würtz Heegaard C; Grønbæk H
    PLoS One; 2018; 13(3):e0192728. PubMed ID: 29522534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into the antioxidant role of arginine in the treatment and the protection for intralipid-induced non-alcoholic steatohepatitis.
    Abu-Serie MM; El-Gamal BA; El-Kersh MA; El-Saadani MA
    Lipids Health Dis; 2015 Oct; 14():128. PubMed ID: 26463841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratracheal exposure to multi-walled carbon nanotubes induces a nonalcoholic steatohepatitis-like phenotype in C57BL/6J mice.
    Kim JE; Lee S; Lee AY; Seo HW; Chae C; Cho MH
    Nanotoxicology; 2015; 9(5):613-23. PubMed ID: 25265201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.